GR3006775T3 - - Google Patents

Info

Publication number
GR3006775T3
GR3006775T3 GR920402400T GR920402400T GR3006775T3 GR 3006775 T3 GR3006775 T3 GR 3006775T3 GR 920402400 T GR920402400 T GR 920402400T GR 920402400 T GR920402400 T GR 920402400T GR 3006775 T3 GR3006775 T3 GR 3006775T3
Authority
GR
Greece
Application number
GR920402400T
Other languages
Greek (el)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR8809218A external-priority patent/FR2633928B1/fr
Priority claimed from FR8902167A external-priority patent/FR2643265B1/fr
Application filed filed Critical
Publication of GR3006775T3 publication Critical patent/GR3006775T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D275/06—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to the ring sulfur atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/06—Peri-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Cephalosporin Compounds (AREA)
GR920402400T 1988-07-07 1993-01-14 GR3006775T3 (instruction)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8809218A FR2633928B1 (fr) 1988-07-07 1988-07-07 Derives de (aza)naphtalenesultame, leurs procedes de preparation et les medicaments les contenant
FR8902167A FR2643265B1 (fr) 1989-02-20 1989-02-20 Derives de (aza)naphto(1,8-cd)isothiazole dioxyde-1,1 leurs procedes de preparation et les medicaments les contenant

Publications (1)

Publication Number Publication Date
GR3006775T3 true GR3006775T3 (instruction) 1993-06-30

Family

ID=26226778

Family Applications (1)

Application Number Title Priority Date Filing Date
GR920402400T GR3006775T3 (instruction) 1988-07-07 1993-01-14

Country Status (18)

Country Link
US (2) US5021420A (instruction)
EP (1) EP0350403B1 (instruction)
JP (1) JP2763791B2 (instruction)
KR (1) KR0138908B1 (instruction)
AU (1) AU620114B2 (instruction)
CA (1) CA1326483C (instruction)
DE (1) DE68904364T2 (instruction)
DK (1) DK335489A (instruction)
ES (1) ES2054057T3 (instruction)
FI (1) FI93114C (instruction)
GR (1) GR3006775T3 (instruction)
HU (1) HU210833B (instruction)
IE (1) IE62364B1 (instruction)
IL (1) IL90858A (instruction)
NO (1) NO179007C (instruction)
NZ (1) NZ229856A (instruction)
PT (1) PT91098B (instruction)
TW (1) TW197440B (instruction)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0429341A3 (en) * 1989-11-20 1991-11-13 Rhone-Poulenc Sante Heterocyclic derivatives, their preparation and pharmaceuticals containing them
FR2656306A1 (fr) * 1989-12-26 1991-06-28 Rhone Poulenc Sante Derives heterocycliques, leur preparation et les medicaments les contenant.
FR2663635A2 (fr) * 1989-12-26 1991-12-27 Rhone Poulenc Sante Derives heterocycliques, leur preparation et les medicaments les contenant.
FR2662696A2 (fr) * 1989-12-13 1991-12-06 Rhone Poulenc Sante Antagonistes de la serotonine, leur preparation et medicaments les contenant.
FR2661177A1 (fr) * 1990-04-23 1991-10-25 Rhone Poulenc Sante Derives du naphtosultame antagonistes de la serotonine, leur preparation et les medicaments les contenant.
FR2675801A1 (fr) * 1991-04-24 1992-10-30 Rhone Poulenc Rorer Sa Piperidines, leur preparation et les medicaments les contenant.
FR2675800A1 (fr) * 1991-04-26 1992-10-30 Rhone Poulenc Rorer Sa Derives heterocycliques antiserotonines leur preparation et les medicaments les contenant.
US5202321A (en) * 1991-06-13 1993-04-13 Merck Frosst Canada, Inc. Thiopyrano[2,3,4-c,d]indoles as inhibitors of leukotriene biosynthesis
FR2687575A1 (fr) * 1992-02-24 1993-08-27 Rhone Poulenc Rorer Sa Application du [[(fluoro-4 phenyl)-4 piperazinyl-1]-3 propyl]-2 2h naphto [1,8-cd] isothiazole dioxyde-1,1 pour obtenir un medicament anorexigene.
US6001827A (en) 1993-12-24 1999-12-14 Suntory Limited Benzothiazine derivative
CA2156849A1 (en) * 1993-12-24 1995-07-06 Akira Mizuno Benzothiazine derivative
US5874429A (en) * 1993-12-24 1999-02-23 Suntory Limited Benzothiazine derivative
GB9416571D0 (en) * 1994-08-16 1994-10-12 Battelle Memorial Institute Novel alkylamino derivatives as sigma 2 selective ligands
SE9902765D0 (sv) * 1999-07-21 1999-07-21 Astra Pharma Prod Novel compounds
US6521630B1 (en) 1999-08-31 2003-02-18 Pfizer Inc. Tetrahydroquinazoline-2,4-diones and therapeutic uses thereof
US6844338B2 (en) 2000-05-18 2005-01-18 Eli Lilly And Company Piperidyindoles as serotonin receptor ligands
GB2362381A (en) * 2000-05-18 2001-11-21 Lilly Co Eli Pharmaceutically active indolyl-piperidines
US7872136B2 (en) 2005-02-25 2011-01-18 Kowa Co., Ltd. Process for production of 4-fluoroisoquinoline-5-sulfonyl halide or salt thereof
WO2008105442A1 (ja) 2007-02-28 2008-09-04 Asahi Kasei Pharma Corporation スルホンアミド誘導体
WO2014009872A1 (en) 2012-07-09 2014-01-16 Lupin Limited Tetrahydroquinazolinone derivatives as parp inhibitors
CN108299411B (zh) * 2017-01-13 2021-02-05 中国人民解放军军事医学科学院毒物药物研究所 4,4-二苯基哌啶类化合物或其可药用盐、药物组合物及用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE755589A (fr) * 1969-09-03 1971-03-02 Janssen Pharmaceutica Nv Benzimidazoolcarbamaten
DE2139084C3 (de) * 1971-08-04 1979-03-01 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz Verfahren zur Herstellung von 4,4-Diphenyl-piperidinen
US4110449A (en) * 1977-05-23 1978-08-29 E. R. Squibb & Sons, Inc. 2-substituted benzisothiazol-3-ones
US4485107A (en) * 1982-11-01 1984-11-27 Janssen Pharmaceutica N.V. [[Bis(aryl)methylene]-1-piperidinyl]alkyl-pyrimidinones
JPS59229556A (ja) * 1983-06-13 1984-12-24 Konishiroku Photo Ind Co Ltd 熱現像カラ−感光要素
IE58370B1 (en) * 1985-04-10 1993-09-08 Lundbeck & Co As H Indole derivatives
GB8510840D0 (en) * 1985-04-29 1985-06-05 Allied Corp Electrical connectors

Also Published As

Publication number Publication date
FI93114B (fi) 1994-11-15
FI93114C (fi) 1995-02-27
DE68904364D1 (de) 1993-02-25
HUT56098A (en) 1991-07-29
JP2763791B2 (ja) 1998-06-11
AU620114B2 (en) 1992-02-13
NO892808D0 (no) 1989-07-06
KR900001707A (ko) 1990-02-27
TW197440B (instruction) 1993-01-01
DK335489A (da) 1990-01-08
AU3790689A (en) 1990-01-11
DK335489D0 (da) 1989-07-06
NO179007B (no) 1996-04-09
IE892189L (en) 1990-01-07
PT91098B (pt) 1994-12-30
ES2054057T3 (es) 1994-08-01
US5036075A (en) 1991-07-30
FI893297A0 (fi) 1989-07-06
IL90858A0 (en) 1990-02-09
US5021420A (en) 1991-06-04
FI893297A7 (fi) 1990-01-08
EP0350403B1 (fr) 1993-01-13
DE68904364T2 (de) 1993-07-15
PT91098A (pt) 1990-02-08
CA1326483C (fr) 1994-01-25
NZ229856A (en) 1990-08-28
KR0138908B1 (ko) 1998-05-15
IE62364B1 (en) 1995-01-25
EP0350403A1 (fr) 1990-01-10
HU210833B (en) 1995-08-28
IL90858A (en) 1994-08-26
NO892808L (no) 1990-01-08
JPH0267274A (ja) 1990-03-07
NO179007C (no) 1996-07-17

Similar Documents

Publication Publication Date Title
FR2626727B1 (instruction)
CH672870GA3 (instruction)
FR2625778B1 (instruction)
IN172164B (instruction)
FR2626696B1 (instruction)
CH673199GA3 (instruction)
FR2625644B1 (instruction)
FR2626435B1 (instruction)
FR2626456B1 (instruction)
DE3991549T (instruction)
FR2626243B1 (instruction)
AU7727287A (instruction)
IN169467B (instruction)
AU7773787A (instruction)
AU2140288A (instruction)
AU7566187A (instruction)
AU6860287A (instruction)
DK63888D0 (instruction)
DK576688D0 (instruction)
DK294488D0 (instruction)
AU1273688A (instruction)
CH678324A5 (instruction)
AU2297688A (instruction)
BG45180A1 (instruction)
BG45331A1 (instruction)